Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Caribou Biosciences Inc (NQ: CRBU ) 1.765 -0.015 (-0.84%) Streaming Delayed Price Updated: 10:56 AM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 377,652 Open 1.790 Bid (Size) 1.760 (16) Ask (Size) 1.770 (20) Prev. Close 1.780 Today's Range 1.740 - 1.800 52wk Range 1.500 - 8.330 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024 September 25, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Expert Ratings For Caribou Biosciences September 03, 2024 Via Benzinga Performance YTD -68.31% -68.31% 1 Month -10.86% -10.86% 3 Month +10.31% +10.31% 6 Month -62.29% -62.29% 1 Year -61.88% -61.88% More News Read More Caribou Biosciences Announces the FDA has Granted Fast Track Designations to CB-010 in Refractory SLE and to CB-012 in Relapsed or Refractory AML September 03, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences to Participate in Upcoming Investor Conferences August 26, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) August 14, 2024 Via Benzinga Evaluating Caribou Biosciences: Insights From 4 Financial Analysts July 17, 2024 Via Benzinga Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences June 04, 2024 Via Benzinga Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer August 12, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update August 06, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board July 09, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Intraday Session June 03, 2024 Via Benzinga Expert Ratings For Caribou Biosciences May 16, 2024 Via Benzinga Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting June 02, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences May 30, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Attention Biotech Investors - Stocks To Watch May 16, 2024 Via Benzinga 3 Underappreciated Stocks That Could 10x in 10 Years May 12, 2024 Via InvestorPlace CRBU Stock Earnings: Caribou Biosciences Misses EPS, Misses Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update May 07, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences to Participate in Upcoming Investor Conferences May 01, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Bragar Eagel & Squire is Investigating Certain Officers and Directors of Caribou, Verrica, and Playstudios on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 27, 2024 From Bragar Eagel & Squire Via GlobeNewswire Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) April 15, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session April 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus April 04, 2024 From Caribou Biosciences, Inc. Via GlobeNewswire Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points March 13, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
